Cytovale

Cytovale Snags $84M To Commercialize Early Sepsis Detection Test

Cytovale, a San Francisco-based medical diagnostics company, raised $84 million in Series C funds to advance the commercialization of its diagnostic test for early sepsis detection. Using standard blood draws, the test provides results in under 10 minutes. It is meant to detect sepsis in patients who present to hospital emergency departments.

By Katie Adams

Startups

Google’s Launchpad Studio reveals first class of machine learning startups

Earlier this week, Launchpad Studio, an acceleration program, unveiled its first cohort of machine learning-focused startups. Throughout the six-month program, the four companies will work with experts from Silicon Valley and Google.

By Erin Dietsche

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.